Dr Gandhi'S Nursing Home Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 29-12-2024
- Paid Up Capital ₹ 0.10 M
as on 29-12-2024
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.78 M
as on 29-12-2024
- Satisfied Charges ₹ 7.95 M
as on 29-12-2024
- Revenue 31.62%
(FY 2022)
- Profit 24.80%
(FY 2022)
- Ebitda -4.74%
(FY 2022)
- Net Worth 6.00%
(FY 2022)
- Total Assets 6.13%
(FY 2022)
About Dr Gandhi'S Nursing Home
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.78 M. The company has closed loans amounting to ₹7.95 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Gandhi, Tanuja Gandhi, and Ritik Gandhi serve as directors at the Company.
- CIN/LLPIN
U85110MH2004PTC145919
- Company No.
145919
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Apr 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dr Gandhi'S Nursing Home?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Gandhi  | Director | 27-Apr-2004 | Current |
| Tanuja Gandhi | Director | 01-Apr-2006 | Current |
| Ritik Gandhi | Director | 16-Feb-2017 | Current |
Financial Performance of Dr Gandhi'S Nursing Home.
Dr Gandhi'S Nursing Home Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.62% increase. The company also saw a substantial improvement in profitability, with a 24.8% increase in profit. The company's net worth moved up by a moderate rise of 6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Gandhi'S Nursing Home?
In 2020, Dr Gandhi'S Nursing Home had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 02 Nov 2006 | ₹0.89 M | Open |
Bank Of Baroda Creation Date: 18 May 2006 | ₹0.89 M | Open |
Bank Of Baroda Creation Date: 19 Feb 2010 | ₹0.42 M | Satisfied |
How Many Employees Work at Dr Gandhi'S Nursing Home?
Unlock and access historical data on people associated with Dr Gandhi'S Nursing Home, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Gandhi'S Nursing Home, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Gandhi'S Nursing Home's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
